Aerion Bioscience
aerion-bioscience.com
Actively hiring
Biotechnology
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
NLC Health Ventures
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
Web presence
top 13%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
NLC Health Ventures Similar startupsby what they do, their industry and backers
Skip to the content About Reveal-Dx is a Seattle-based software company whose vision is to dramatically improve lung cancer outcomes. We do…
FirstLook Lung is a blood-based test that helps identify lung cancer risk before or alongside LDCT, for USPSTF-eligible adults. From DELFI…
Company Focus Accurate prognosis of early stage melanoma is limited in current care Cutaneous melanoma is the most deadly form of skin…
Agamon makes it easy to bring more patients back for radiology follow-ups. Manage Lung Cancer Screening programs, urgent and findings…
Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use…
The biopsy and treatment of lung cancer in a single hospital visit – reducing time-to-treat from weeks to minutes; relieving hospital…
Overview
Company Focus Our mission is to pioneer early lung cancer detection and save lives. Lung cancer is the second most common cancer worldwide, with more than 2.2 million new cases reported in 2020.